ADDvise Group Toekomstige groei

Future criteriumcontroles 4/6

ADDvise Group zal naar verwachting groeien in winst en omzet met respectievelijk 21.1% en 8.5% per jaar. De winst per aandeel zal naar verwachting groeien met 21.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 17% zijn.

Belangrijke informatie

21.1%

Groei van de winst

21.6%

Groei van de winst per aandeel

Medical Equipment winstgroei	36.6%
Inkomstengroei	8.5%
Toekomstig rendement op eigen vermogen	17.0%
Dekking van analisten	Low
Laatst bijgewerkt	22 Nov 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

OM:ADDV B - Toekomstschattingen van analisten en financiële gegevens uit het verleden (SEK Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	1,914	181	204	282	2
12/31/2025	1,798	136	206	340	2
12/31/2024	1,701	118	-209	92	2
9/30/2024	1,634	114	20	64	N/A
6/30/2024	1,550	138	70	98	N/A
3/31/2024	1,483	111	86	106	N/A
12/31/2023	1,379	104	157	175	N/A
9/30/2023	1,302	102	208	225	N/A
6/30/2023	1,218	101	189	202	N/A
3/31/2023	1,105	117	211	226	N/A
12/31/2022	959	81	96	110	N/A
9/30/2022	793	55	66	35	N/A
6/30/2022	660	19	34	18	N/A
3/31/2022	545	0	-4	-2	N/A
12/31/2021	469	3	6	10	N/A
9/30/2021	410	7	-32	9	N/A
6/30/2021	380	11	-4	20	N/A
3/31/2021	364	20	42	47	N/A
12/31/2020	359	15	56	57	N/A
9/30/2020	365	17	42	47	N/A
6/30/2020	369	12	33	38	N/A
3/31/2020	360	2	12	17	N/A
12/31/2019	354	4	5	11	N/A
9/30/2019	325	0	-4	0	N/A
6/30/2019	306	-2	1	2	N/A
3/31/2019	280	-1	-3	3	N/A
12/31/2018	271	-1	-5	0	N/A
9/30/2018	260	-7	-19	-13	N/A
6/30/2018	248	-7	N/A	-16	N/A
3/31/2018	250	-5	N/A	-17	N/A
12/31/2017	244	-6	N/A	-19	N/A
9/30/2017	235	-3	N/A	-19	N/A
6/30/2017	229	1	N/A	-27	N/A
3/31/2017	214	6	N/A	-35	N/A
12/31/2016	198	0	N/A	-32	N/A
9/30/2016	183	-6	N/A	-25	N/A
6/30/2016	173	-13	N/A	-13	N/A
3/31/2016	156	-18	N/A	-15	N/A
12/31/2015	151	-11	N/A	-4	N/A
9/30/2015	160	-8	N/A	-7	N/A
6/30/2015	154	-4	N/A	-6	N/A
3/31/2015	151	-4	N/A	5	N/A
12/31/2014	144	-5	N/A	-9	N/A
9/30/2014	138	-6	N/A	-9	N/A
6/30/2014	137	-4	N/A	4	N/A
3/31/2014	133	-3	N/A	6	N/A
12/31/2013	125	-4	N/A	-6	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei ADDV B ( 21.1% per jaar) ligt boven de spaarquote ( 1.2% ).

Winst versus markt: De winst van ADDV B ( 21.1% per jaar) zal naar verwachting sneller groeien dan de Swedish markt ( 15% per jaar).

Hoge groeiwinsten: De winst van ADDV B zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van ADDV B ( 8.5% per jaar) zal naar verwachting sneller groeien dan de markt Swedish ( -0.04% per jaar).

Hoge groei-inkomsten: De omzet van ADDV B ( 8.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen ADDV B zal naar verwachting over 3 jaar laag zijn ( 17 %).

ADDvise Group Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

ADDvise Group AB (publ) Provides Earnings Guidance for the Year 2023

ADDvise Group AB (Publ) Provides Earnings Guidance for the Financial Year 2022

Recent updates

ADDvise Announces Restructuring of its Two Existing Business Areas

ADDvise Group AB (publ) to Report Q1, 2025 Results on Apr 16, 2025

ADDvise Group AB (publ), Annual General Meeting, May 06, 2025

ADDvise Group AB (publ) Announces Chief Financial Officer Changes

Addvise Group AB (Publ) Announces Chief Executive Officer Changes

ADDvise Group AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 100 million.

Addvise Group AB (Publ) Announces Erland Pontusson Decline Re-Election from the Board

ADDvise Group AB (publ) (OM:ADDV A) acquired Axelerist, Inc. for $29.4 million.

ADDvise Group AB (publ) to Report First Half, 2024 Results on Jul 18, 2024

ADDvise Group AB (publ) (OM : ADDV A) completed the acquisition of Diabetic Supply Inc.

ADDvise Group AB (publ) Announces Management Changes

Addvise Group AB (Publ) Appoints Oliver Humlen as Member of the Executive Management Team

ADDvise Group AB (publ) Provides Earnings Guidance for the Year 2023

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Innovative Endoscopy Components, L.L.C. for $11.75? million.

ADDvise Group AB (publ) (OM:ADDV A) has signed a Letter of Intent to acquire Kolplast CI S.A. for approximately BRL 210 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire X-Ray Cassette Repair Company, Inc. for approximately $15 million.

ADDvise Group Appoints Fredrik Mella as Senior Vice President Alongside His Current Role as Chief Operating Officer

ADDvise Group AB (publ) to Report Fiscal Year 2022 Final Results on Apr 05, 2023

ADDvise Group AB (publ), Annual General Meeting, May 05, 2023

ADDvise Group AB (publ) (OM:ADDV A) entered into a letter of intent to acquire Clinichain Holding B.V. for €33.80 million.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Seebreath AB from the shareholders.

ADDvise Group AB (publ) Announces Executive Changes

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Surplus Diabetic, Inc for $19.5 million.

Addvise Group AB (Publ) Not to Propose Any Dividend for the Financial Year 2021

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Surplus Diabetic, Inc. for $19.5 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Zevex Physical Evaluation for $7.3 million.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Southern Life Systems, Inc.

ADDvise Group AB (Publ) Provides Earnings Guidance for the Financial Year 2022

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Southern Life Systems, Inc. for $11 million.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Medisuite, LLC.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of MRC Systems Ltd.

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire Medisuite, LLC for $10.3 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire Graham Medical Technologies, LLC for $5.8 million.

ADDvise Group AB (publ) has announced a Derivatives Offering in the amount of SEK 27.977487 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire MRC Systems Ltd for $8 million.

ADDvise Group AB Announces Nomination Committee

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven